Structure-activity study of inhibition of amphotericin B (Fungizone) binding to sterols, toxicity to cells, and lethality to mice by esters of sucrose

The effects of four monoesters of sucrose with different acyl chain lengths (palmitate, C16; myristate, C14; laurate, C12; and caprate, C10) on the aggregation state of amphotericin B (AmB), its binding to cholesterol and ergosterol, its toxicity to cells, and its lethality to mice were determined. In solution, all four of these esters inhibited AmB binding to cholesterol more than to ergosterol; this effect correlated with the ester-induced shift from the mainly aggregated form of AmB to the mainly monomeric form. In experiments with cells, the esters inhibited the toxicity of AmB to mouse erythrocytes and cultured mouse fibroblast L-929 cells more than its toxicity to Candida albicans cells. When injected intravenously with AmB, these esters decreased AmB lethality to mice. In all of these assays, the ester with the shortest chain length (caprate) was much less potent than the other three esters. Our results indicate a correlation between in vitro and in vivo assays and suggest that the in vitro and in vivo selectivity of AmB may be enhanced by surface-active agents which modulate the aggregation state of AmB.

[1]  J. Bolard,et al.  Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations. , 1990, Biochimica et biophysica acta.

[2]  G. Medoff,et al.  Concentration dependent dual effect of the monolauryl ester of sucrose on the antifungal activity and absorption spectra of amphotericin B (Fungizone). , 1989, Biochimica et biophysica acta.

[3]  S. Schreier,et al.  Polydispersity of aggregates formed by the polyene antibiotic amphotericin B and deoxycholate. A spin label study. , 1989, Biochimica et biophysica acta.

[4]  R. Mehta Liposomes as drug carriers for polyene antibiotics , 1989 .

[5]  F. Szoka,et al.  Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes. , 1989, The Journal of infectious diseases.

[6]  A. Janoff Liposomes and Lipid Structures as Carriers of Amphotericin B , 1989 .

[7]  G. Medoff,et al.  Effects of the detergent sucrose monolaurate on binding of amphotericin B to sterols and its toxicity for cells. , 1988, Biochemical and biophysical research communications.

[8]  M. C. Popescu,et al.  Unusual lipid structures selectively reduce the toxicity of amphotericin B. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[9]  I. Gruda,et al.  Effect of the aggregation state of amphotericin B on its interaction with ergosterol. , 1988, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[10]  S. Davis,et al.  Lipid Emulsions as Drug Delivery Systems , 1987, Annals of the New York Academy of Sciences.

[11]  F. Szoka,et al.  Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B , 1987, Antimicrobial Agents and Chemotherapy.

[12]  J. Bolard How do the polyene macrolide antibiotics affect the cellular membrane properties? , 1986, Biochimica et biophysica acta.

[13]  G. Lopez-Berestein,et al.  Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. , 1984, Biochimica et biophysica acta.

[14]  R. Ernst,et al.  Biological effects of surfactants, IV. Effects of non-ionics and amphoterics on HeLa cells. , 1980, Toxicology.

[15]  R. Ernst,et al.  BIOLOGICAL EFFECTS OF SURFACTANTS , 1971 .